Overview

A Study to Investigate a New Treatment in Patients With Parkinson's Disease

Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial conducted in patients with Parkinson's Disease is to study the relationship between patient individual profile and their response to IPT803 Adjunct Treatment (treatment response being characterized by movements improvement).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tools4Patient